亚虹医药-U
(688176)
| 流通市值：34.01亿 | | | 总市值：51.24亿 |
| 流通股本：3.78亿 | | | 总股本：5.70亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 871,264,190.39 | 628,197,162.91 | 473,364,827.48 | 1,168,116,655.42 |
| 应收票据及应收账款 | 68,294,635.47 | 59,901,176.72 | 43,111,819.61 | 31,743,068.86 |
| 应收账款 | 68,294,635.47 | 59,901,176.72 | 43,111,819.61 | 31,743,068.86 |
| 预付款项 | 20,650,221.46 | 17,629,542.49 | 21,357,449.99 | 14,522,671.89 |
| 其他应收款合计 | 15,245,454.41 | 11,626,408.97 | 12,586,437.42 | 16,828,237.91 |
| 存货 | 7,157,335.8 | 5,837,584.88 | 2,156,763.7 | 1,890,647.08 |
| 一年内到期的非流动资产 | 151,201,232.88 | 150,539,583.32 | - | - |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,780,132,063.57 | 1,530,945,418.21 | 1,598,463,174.92 | 2,089,406,719.53 |
| 非流动资产: | | | | |
| 其他债权投资 | 152,678,632.83 | 453,764,749.66 | 481,774,517.12 | 120,908,115.29 |
| 其他权益工具投资 | 20,438,650.25 | 20,453,205.23 | 12,318,308.46 | 12,528,914.4 |
| 固定资产 | 26,669,477.82 | 28,320,738.66 | 28,033,062.56 | 29,553,236.85 |
| 使用权资产 | 53,126,811.08 | 57,129,831.3 | 57,126,018.09 | 50,933,340.2 |
| 无形资产 | 51,821,202.14 | 53,978,664.35 | 56,136,126.59 | 57,515,583.72 |
| 长期待摊费用 | 5,284,049.33 | 5,961,794.89 | 6,833,194.25 | 7,708,107.62 |
| 递延所得税资产 | 2,138,008.81 | 2,091,061.96 | 1,914,294.95 | 1,826,317.91 |
| 其他非流动资产 | 69,274,335.14 | 70,346,439.53 | 71,243,831.23 | 73,631,779.26 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 381,431,167.4 | 692,046,485.58 | 715,379,353.25 | 354,605,395.25 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,161,563,230.97 | 2,222,991,903.79 | 2,313,842,528.17 | 2,444,012,114.78 |
| 流动负债: | | | | |
| 短期借款 | 107,855,747.67 | 66,246,159 | 66,200,000 | 109,900,000 |
| 应付票据及应付账款 | 35,126,942.58 | 49,544,619.95 | 40,637,372.83 | 43,030,708.48 |
| 应付账款 | 35,126,942.58 | 49,544,619.95 | 40,637,372.83 | 43,030,708.48 |
| 合同负债 | 242,151.87 | 306,405.76 | 2,153,989.06 | 1,939,809.44 |
| 应付职工薪酬 | 20,174,832.91 | 27,281,040.17 | 24,425,280.35 | 20,796,667.52 |
| 应交税费 | 4,214,843.54 | 5,782,957.71 | 4,886,996.06 | 4,395,829.44 |
| 其他应付款合计 | 36,882,664.37 | 31,567,950.85 | 23,870,092.58 | 16,606,370.53 |
| 一年内到期的非流动负债 | 16,705,304.68 | 16,330,697.32 | 15,716,469.01 | 9,620,199.64 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 221,202,487.62 | 197,059,830.76 | 177,890,199.89 | 206,289,585.05 |
| 非流动负债: | | | | |
| 租赁负债 | 45,718,575.27 | 49,950,414.66 | 50,477,644.38 | 47,563,516.9 |
| 递延收益 | 5,386,418.92 | 5,607,859.87 | 5,823,490 | 6,015,476.46 |
| 递延所得税负债 | - | - | 2,237 | - |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 51,104,994.19 | 55,558,274.53 | 56,303,371.38 | 53,578,993.36 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 272,307,481.81 | 252,618,105.29 | 234,193,571.27 | 259,868,578.41 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 570,000,000 | 570,000,000 | 570,000,000 | 570,000,000 |
| 资本公积 | 2,888,592,532.42 | 2,883,617,895.78 | 2,874,307,329.49 | 2,868,692,461.63 |
| 减:库存股 | 50,059,352.74 | 50,059,352.74 | 47,825,960.06 | 23,001,886.26 |
| 其他综合收益 | -5,588,206.01 | -5,538,025.87 | -2,605,505.37 | -4,329,361.12 |
| 未分配利润 | -1,512,145,919.36 | -1,428,615,181.08 | -1,315,547,450.98 | -1,228,697,282.25 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,890,799,054.31 | 1,969,405,336.09 | 2,078,328,413.08 | 2,182,663,932 |
| 少数股东权益 | -1,543,305.15 | 968,462.41 | 1,320,543.82 | 1,479,604.37 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,889,255,749.16 | 1,970,373,798.5 | 2,079,648,956.9 | 2,184,143,536.37 |
| 负债和股东权益合计 | 2,161,563,230.97 | 2,222,991,903.79 | 2,313,842,528.17 | 2,444,012,114.78 |
| 公告日期 | 2025-04-30 | 2025-04-19 | 2024-10-30 | 2024-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |